0000899243-18-010882.txt : 20180427 0000899243-18-010882.hdr.sgml : 20180427 20180427162625 ACCESSION NUMBER: 0000899243-18-010882 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180425 FILED AS OF DATE: 20180427 DATE AS OF CHANGE: 20180427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Invest Corp CENTRAL INDEX KEY: 0001534428 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 18784321 BUSINESS ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 0119611363362 MAIL ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 167 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6176795500 MAIL ADDRESS: STREET 1: 167 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-04-25 0 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001534428 Pillar Invest Corp C/O IDERA PHARMACEUTICALS, INC. 167 SIDNEY STREET CAMBRIDGE MA 02139 0 0 1 0 Common Stock 2018-04-25 4 X 0 1200000 0.00 A 0 I See Footnote Warrants 0.47 2018-04-25 4 X 0 1200000 0.00 D 2013-05-04 2018-05-04 Common Stock 1200000 0 I See Footnote 1,200,000 of such warrants exercised by Participations Besancon (the "Besancon Warrants"). Participations Besancon is a fund advised by Pillar Invest Corporation ("Pillar GP"). Pillar GP disclaims Section 16 beneficial ownership of the Besancon Warrants and the common stock underlying such warrants and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, resulting from fees payable to Pillar GP in its capacity as investment advisor to Besancon. Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person 2018-04-27